Abiopharma

Clinical trial NCT05865405 updates: 1. completion date: 2026-08-15 → 2027-01-15 2. primary completion date: 2026-08-15 → 2027-01-15

Clinical trial NCT06392386 updates: 1. completion date: 2026-09-30 → 2027-09-01 2. primary completion date: 2026-09-30 → 2027-09-01

Clinical trial NCT07361601 updates: 1. status: NOT_YET_RECRUITING → WITHDRAWN 2. start date: 2026-07-01 → 2026-07-02 3. enrollment: 285 → 0 participants 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT04255849 updates: 1. completion date: 2026-07-31 → 2026-12-31 2. primary completion date: 2026-07-31 → 2026-12-31

Clinical trial NCT04889716: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT05246267 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-06-01 → 2027-08-01 3. primary completion date: 2026-06-01 → 2027-08-01 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT04191135: status: COMPLETED → TERMINATED.

Clinical trial NCT06297226: primary completion date: 2027-06-30 → 2026-07-31.

Clinical trial NCT03554356 updates: 1. primary completion date: 2026-08-01 → 2026-08-27 2. collaborators added: Pentax Medical, PENTAX of America, Inc.

Clinical trial NCT06897475 updates: 1. completion date: 2027-01-01 → 2027-06-01 2. primary completion date: 2026-12-01 → 2027-05-01 3. enrollment: 240 → 200 participants